Table 1 DLBCL characteristics at diagnosis (n = 52).

From: The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma

Characteristics

Number of patients (%)

Age, at diagnosis (median)

45 years (range, 17–63)

Sex (male/female)

30 (57.7%)/22 (42.3%)

ECOG-PS score > 1

13 (25.0%)

Ann Arbor stage

 Stage I–II

16 (30.8%)

 Stage III–IV

36 (69.2%)

B symptom

15 (28.8%)

 > 1 Extranodal site

24 (46.2%)

Bone marrow involvement

13 (25.0%)

 Complex karyotypes

8/13 (61.5%)

LDH, at diagnosis (median)

650 IU/L (229–1303)

 Elevated LDH

38 (73.1%)

IPI risk

 Low

15 (28.8%)

 Low-intermediate

13 (25.0%)

 High-intermediate

14 (26.9%)

 High

10 (19.2%)

Pathologic diagnosis

 ABC type

32 (61.5%)

 GCB type

13 (25.0%)

 T-cell/Histiocytic rich

3 (5.8%)

 Unclassifiable

3 (5.8%)

 Anaplastic variant

1 (1.9%)

Double-Hit

4 (7.7%)

  1. ABC type, activated B-cell type; DLBCL, diffuse large B cell lymphoma; ECOG-PS, Eastern Cooperative Oncology Group-Performance Status; GCB type, germinal center B-cell type; IPI, international prognostic index; LDH, lactate dehydrogenase.
Back to article page